Fig. 1From: The seroprevalence and kinetics of IgM and IgG in the progression of COVID-19The seroprevalence and concentration comparison of COVID-19 IgG and IgM in diagnosed patients stratified by region and symptom onset interval. a The seroprevalence of COVID-19 IgG and IgM stratified by symptom onset interval. b The seroprevalence of COVID-19 IgM stratified by symptom onset interval and region. c The seroprevalence of COVID-19 IgG stratified by symptom onset interval and regionBack to article page